PPD, Inc. Selected As Member Of New Medical Countermeasure Clinical Studies Network To Address Public Health Emergencies

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) today announced that the Biomedical Advanced Research and Development Authority (BARDA) has chosen the company as one of a select group to design and conduct clinical studies needed to develop medical countermeasures – drugs, vaccines and diagnostic tests – that help protect health against bioterrorism, pandemic influenza and other public health emergencies.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC